MEGAN MAYES: Open Payments
NPI 1003311309 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 33 payments from 20 companies in 2025. Trend: 2023 $1,581 · 2024 $1,293 · 2025 $1,079
Food & beverage: $1,010Education: $69
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $154 |
| ABIOMED | 1 | $144 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $123 |
| GlaxoSmithKline, LLC. | 1 | $98 |
| Janssen Biotech, Inc. | 2 | $88 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Amgen Inc. | 1 | $61 |
| Novo Nordisk Inc | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: Korlym, BENLYSTA, TREMFYA, TAVNEOS, Auvelity, CAPLYTA, Kerendia, Symbravo.
Industry payments across IN — which companies pay providers there.
